JAMES KATES: Open Payments
NPI 1760565600 · DOVER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 26 payments from 13 companies in 2025. Trend: 2023 $84 · 2024 $324 · 2025 $600
Food & beverage: $600
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $179 |
| Otsuka America Pharmaceutical, Inc. | 3 | $81 |
| Janssen Pharmaceuticals, Inc | 4 | $79 |
| ABBVIE INC. | 2 | $46 |
| Lundbeck LLC | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Biogen, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Indivior Inc. | 1 | $19 |
Products named: Auvelity, REXULTI, INVEGA SUSTENNA, VRAYLAR, SPRAVATO, ZURZUVAE, CAPLYTA, TRINTELLIX.
Industry payments across NH — which companies pay providers there.
